Oxford Nanopore Technologies plc (LON:ONT)
138.40
+1.40 (1.02%)
Nov 3, 2025, 1:43 PM BST
LON:ONT Revenue
Oxford Nanopore Technologies had revenue of 105.60M GBP in the half year ending June 30, 2025, with 22.79% growth. This brings the company's revenue in the last twelve months to 204.69M, up 22.01% year-over-year. In the year 2024, Oxford Nanopore Technologies had annual revenue of 183.19M with 7.97% growth.
Revenue (ttm)
204.69M
Revenue Growth
+22.01%
P/S Ratio
6.45
Revenue / Employee
154.48K
Employees
1,382
Market Cap
1.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 183.19M | 13.52M | 7.97% |
| Dec 31, 2023 | 169.67M | -28.94M | -14.57% |
| Dec 31, 2022 | 198.60M | 64.94M | 48.59% |
| Dec 31, 2021 | 133.66M | 19.80M | 17.39% |
| Dec 31, 2020 | 113.86M | 61.80M | 118.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Oxford Nanopore Technologies News
- 18 days ago - Oxford Nanopore Announces PromethION Plus Flow Cell and Human Genetics Updates at ASHG 2025 - Business Wire
- 25 days ago - Bio-Techne (TECH) Expands Partnership with Oxford Nanopore Technologies - GuruFocus
- 2 months ago - Half Year 2025 Oxford Nanopore Technologies PLC Earnings Presentation Transcript - GuruFocus
- 2 months ago - Oxford Nanopore Technologies plc (ONTTF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Oxford Nanopore Technologies plc 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - FTSE Falls as Starmer Resets Government - Investomania
- 2 months ago - UK Stock Market News: Michelmersh Brick, WizzAir, Oxford Nanopore - The Armchair Trader
- 3 months ago - ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology - Business Wire